Paratek Pharmaceuticals, Inc.
PRTK · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$14,552 | -$20,143 | -$7,157 | -$20,882 |
| Dep. & Amort. | $46 | $47 | $86 | $129 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,226 | $2,146 | $1,985 | $3,980 |
| Change in WC | $9,307 | $28,011 | -$16,378 | $3,023 |
| Other Non-Cash | $1,197 | $1,029 | $1,351 | $1,331 |
| Operating Cash Flow | -$1,776 | $11,090 | -$20,113 | -$12,419 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$32 | -$36 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$15,160 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $30,000 | $0 |
| Other Inv. Act. | $0 | $0 | $15,196 | $0 |
| Investing Cash Flow | $0 | -$32 | $30,000 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | -$1 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$565 | -$280 | -$2,726 | $1 |
| Financing Cash Flow | -$565 | -$280 | -$2,726 | $1 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$2,341 | $10,778 | $7,161 | -$12,418 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $45,151 | $34,373 | $27,212 | $39,630 |
| End Cash | $42,810 | $45,151 | $34,373 | $27,212 |
| Free Cash Flow | -$1,776 | $11,058 | -$20,149 | -$12,419 |